Clinical Research & Trial Programs
Transparent, rigorous, and ethically governed clinical research advancing breakthrough therapies across oncology, neurology, immunology, and rare diseases.
Research Phases & Methodology
Safety & Dosing
Initial human testing to evaluate safety, dosage range, and pharmacokinetics in 20–100 healthy volunteers or patients.
Efficacy & Side Effects
Expanded studies to assess therapeutic efficacy and further evaluate safety in 100–300 targeted patient populations.
Pivotal Confirmation
Large-scale, randomized controlled trials across multiple regions to confirm efficacy, monitor adverse reactions, and compare standard treatments.
Post-Marketing Surveillance
Long-term real-world data collection to monitor rare long-term effects, optimize dosing, and explore new indications.
Active Clinical Trials
Patient Participation
Participating in a clinical trial provides access to cutting-edge treatments, comprehensive medical monitoring, and contributes to scientific advancement.
- Free screening & trial-related care
- Dedicated patient coordinators
- Flexible scheduling & travel support
- Full transparency on risks & benefits
Eligibility varies by trial. All participants must provide informed consent and meet inclusion criteria.
Researcher & Institutional Partnerships
Aevum Zenth collaborates with leading academic medical centers, CROs, and independent research institutions to accelerate therapeutic development.
- Streamlined site initiation processes
- Dedicated clinical project managers
- Competitive site funding & compensation
- Real-time data dashboards & monitoring
Explore Opportunities or Initiate Collaboration
\nWhether you're a patient seeking novel treatments, a physician interested in site activation, or a biotech partner exploring co-development, our clinical operations team is ready to assist.